Yes—methylphenidate is a controlled drug
Methylphenidate is a controlled substance in many countries because it has potential for misuse and dependence. In the United States, it is regulated as a Schedule II controlled substance under federal law.
What schedules mean (and why it matters)
In the U.S., Schedule II means methylphenidate is considered to have a high potential for abuse, with accepted medical use, and limited ability to dispense without close regulatory control (for example, strict prescription rules).
Is it controlled everywhere?
Control status depends on the country. Many jurisdictions place methylphenidate under controlled-drug laws (often at a level similar to Schedule II or its local equivalent), but the exact classification can vary by national regulator.
What patients and pharmacists should expect
Because it is controlled, methylphenidate prescriptions are typically subject to tighter rules than non-controlled medicines. Common impacts include restrictions on prescribing, refills, and how prescriptions are dispensed (which can differ by country and by specific formulation).
Which formulations are affected?
The controlled status generally applies to methylphenidate itself and methylphenidate-containing products (including common brand and generic formulations used for ADHD and narcolepsy), subject to the same drug-control classification in that jurisdiction.
Sources
No source links were provided in your prompt.